Breast Cancer

• CLINICAL_TRIALS trial_result · 2023-08-04
  Clinical Trial Update: A Study of Foretinib in Patients With Recurrent/Metastatic Breast Cancer [Phase 2]

  Phase 2 clinical trial update for foretinib in patients with recurrent/metastatic breast cancer has been completed.

• CLINICAL_TRIALS trial_result · 2023-08-04
  Clinical Trial Update: OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer [Phase 2]

  Phase 2 trial of OGX-011 with docetaxel in locally advanced or metastatic breast cancer completed.

• CLINICAL_TRIALS trial_result · 2023-08-03
  Clinical Trial Update: Pain Control for Breast Cancer Patients Receiving Injection of Radioactive Tracer [Phase 3]

  A Phase 3 clinical trial evaluating pain control for breast cancer patients receiving a radioactive tracer injection has completed with resu…

• CLINICAL_TRIALS trial_result · 2023-08-03
  Clinical Trial Update: Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene [Phase 1, Phase 2]

  Phase 1/2 clinical trial studying A166 in patients with various HER2-expressing or HER2-amplified cancers has completed.

• CLINICAL_TRIALS trial_result · 2023-08-03
  Clinical Trial Update: Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ [Phase 3]

  A Phase 3 trial update on delayed sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) is currently recruiting.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2023-08-03
  Clinical Trial Update: Radiation Therapy in Treating Women With Early Stage Breast Cancer [Phase 2]

  Phase 2 clinical trial update on radiation therapy for women with early-stage breast cancer.

• CLINICAL_TRIALS trial_result · 2023-08-02
  Clinical Trial Update: Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer [Phase 2]

  Phase 2 trial evaluating pegfilgrastim and darbepoetin alfa as supportive care in adjuvant chemotherapy for breast cancer has completed.

• CLINICAL_TRIALS trial_result · 2023-08-01
  Clinical Trial Update: A Study of Accelerated 3 Fraction Photon,Proton or Brachytherapy for Early Invasive and Noninvasive Breast Ca [Phase 2]

  This Phase 2 trial evaluated accelerated 3-fraction radiotherapy using photon, proton, or brachytherapy for early invasive and noninvasive b…

• CLINICAL_TRIALS trial_result · 2023-08-01
  Clinical Trial Update: The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer [Phase 2]

  Phase 2 trial evaluating the effect of simvastatin on breast cancer cell growth in women with stage I-II invasive breast cancer has complete…

• CLINICAL_TRIALS trial_result · 2023-08-01
  Clinical Trial Update: Evaluation in the Treatment of Neuropathic Pain Post Breast Surgery [Phase 3]

  Phase 3 clinical trial evaluating a treatment for neuropathic pain after breast surgery in breast cancer patients has completed.

• CLINICAL_TRIALS trial_result · 2023-08-01
  Clinical Trial Update: PD-1 +/- IL-4 Inhibition in ER+ Breast Cancer [Phase 2]

  Phase 2 trial evaluating PD-1 with or without IL-4 inhibition in ER+ breast cancer is ongoing; current status is unknown.

• CLINICAL_TRIALS trial_result · 2023-08-01
  Clinical Trial Update: A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression. [Phase 1, Phase 2]

  A clinical trial evaluating SHR-A1811 in combination with capecitabine for unresectable or metastatic breast cancer with low HER2 expression…

• CLINICAL_TRIALS trial_result · 2023-07-27
  Clinical Trial Update: A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer [Phase 3]

  A Phase 3 clinical trial evaluating BPI-16350 in combination with fulvestrant for HR+ HER2- locally advanced, recurrent, or metastatic breas…

• CLINICAL_TRIALS trial_result · 2023-07-27
  Clinical Trial Update: A Single Arm Pilot Study to Refine a Novel Approach to Exercise Promotion Based on Affect-regulation [NA]

  A single-arm pilot study evaluating a novel affect-regulation based approach to exercise promotion in individuals with breast cancer; study …

• CLINICAL_TRIALS trial_result · 2023-07-20
  Clinical Trial Update: SHR-A1811 Versus Investigator's Chemotherapy in Recurrent/Metastatic Breast Cancer Clinical Trial [Phase 3]

  Phase 3 clinical trial update comparing SHR-A1811 to investigator's chemotherapy in recurrent/metastatic breast cancer is currently recruiti…

• CLINICAL_TRIALS trial_result · 2023-07-19
  Clinical Trial Update: Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast Cancer [Phase 2]

  A Phase 2 clinical trial evaluating stereotactic radiation combined with immunotherapy in advanced triple negative breast cancer has complet…

• CLINICAL_TRIALS trial_result · 2023-07-14
  Clinical Trial Update: A Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BC [Phase 2]

  Phase 2 trial evaluating eribulin in combination with HP neoadjuvant therapy for HER2-positive breast cancer (status: unknown).

• CLINICAL_TRIALS trial_result · 2023-07-13
  Clinical Trial Update: Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer [Phase 3]

  Phase 3 trial comparing Utidelone to Docetaxel in HER2-negative locally advanced or metastatic breast cancer is currently recruiting.

• CLINICAL_TRIALS trial_result · 2023-07-13
  Clinical Trial Update: A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) [Phase 1, Phase 2]

  Clinical trial update for KVA12123 as a standalone and in combination with pembrolizumab in advanced solid tumors; current status is unknown…

• CLINICAL_TRIALS trial_result · 2023-07-07
  Clinical Trial Update: A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer [Phase 2]

  Phase 2 clinical trial evaluating ONM-100 as an intraoperative fluorescence imaging agent for cancer detection has completed enrollment with…

• CLINICAL_TRIALS trial_result · 2023-07-07
  Clinical Trial Update: Anti-hormonal Therapie With Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer [Phase 2]

  Phase 2 trial update on anti-hormonal therapy with ribociclib in HR-positive, HER2-negative metastatic breast cancer.

• CLINICAL_TRIALS trial_result · 2023-07-06
  Clinical Trial Update: Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer [Phase 3]

  Phase 3 trial evaluating amcenestrant plus palbociclib as first-line therapy for ER-positive, HER2-negative advanced breast cancer was termi…

• CLINICAL_TRIALS trial_result · 2023-07-03
  Clinical Trial Update: Study of TFX06 in Women With Advanced Breast Cancer. [Phase 1, Phase 2]

  A trial update for TFX06 in women with advanced breast cancer spanning Phase 1 and Phase 2; current status is unknown.

• CLINICAL_TRIALS trial_result · 2023-07-03
  Clinical Trial Update: Histological Response Rate After Mastectomy and Immediate Breast Reconstruction at the End of Neoadjuvant Chemotherapy and Radiotherapy [Phase 2]

  Phase 2 clinical trial update evaluating histological response after mastectomy and immediate breast reconstruction following neoadjuvant ch…

• CLINICAL_TRIALS trial_result · 2023-06-29
  Clinical Trial Update: Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients [Phase 3]

  A Phase 3 randomized study comparing CMF to Goserelin + Tamoxifen in premenopausal receptor-positive early-stage breast cancer has completed…